IFNB1 and COVID-19: As shown in Figure 3A, the standard of care (SOC) was the most well-connected treatment, with chloroquine (CQ), hydroxychloroquine (HCQ), CQ/HCQ, convalescent plasma (CP), CP/SOC, remdesivir, remdesivir/SOC, lopinavir/ritonavir (LPV/r), interferon-beta-1b (IFN-β-1b), C-IVIG (i.e., a hyperimmune anti-COVID-19 intravenous immunoglobulin), ivermectin/doxycycline, IFN-β/SOC, tocilizumab, ruxolitinib/SOC, methylprednisolone, azithromycin/SOC, and auxora directly connected to it.